HARBIN PHARMACEUTICAL GROUP CO LTD revenue for the last year amounted to 15.46 B CNY, the most of which — 6.15 B CNY — came from its highest performing source at the moment, Wholesale Medical, the year earlier bringing 5.93 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought HARBIN PHARMACEUTICAL GROUP CO LTD 14.39 B CNY, and the year before that — 13.46 B CNY.